CRS Satellite Meeting

 

Oral Multi-Particulate Drug Delivery Systems:
Challenges and Scope
April 3-4, 2008
Orlando, FL USA

Generously Co-sponsored by: BASF Corporation, Colorcon, Inc., Dow Wolff Cellulosics, and Elan Corporation

Save the date and register now for this exciting and must-attend CRS satellite meeting! Be sure to print, complete and submit your registration form Adobe PDF File and payment by March 31, 2008.

The meeting will take place the Embassy Suites Lake Buena Vista Resort, Orlando, Florida. The $175 a night (plus tax) suite rate is for single or double occupancy and includes a cooked-to-order breakfast each morning as well as the manager's reception each evening. The hotel also provides complimentary, scheduled shuttle service to the Walt Disney World theme parks.

Housing is Open!

We encourage you to make your hotel reservations early as it is Spring Break time (high season) in Florida. The deadline for making hotel reservations is March 26, 2008. After this date hotel rooms may not be available at the CRS rate. The discounted CRS rate is offered three days pre- and post-meeting dates, based on availability.

Suite Rate: $175.00 Single/Double plus applicable tax.

To make hotel reservations via telephone or online please follow these instructions:

By Telephone: Call Embassy Suites at +1.800.Embassy (+1.800.362.2779). Inform the reservationist that you are attending the CRS Satellite Meeting at the Embassy Suites Lake Buena Vista Resort, in Orlando, Florida, and provide your arrival and departure dates.

Reserve Online: Go to www.embassysuiteslbv.com and enter the Group Code CON. You must enter the group code to receive the discounted CRS rate.

Embassy Suites Lake Buena Vista Resort
8100 Lake Avenue
Orlando, FL 32836
Direct Hotel Tel: +1.407.239.1144
Direct Hotel Fax: +1.407.239.1718

Embassy Suites Lake Buena Vista Resort is about 17 miles from the Orlando International Airport.

Cab fare is a flat rate of $50.00, one way.

Program

This CRS Satellite Meeting will be an excellent opportunity for those new to the use of multi-particulates, as well as those who are familiar and experienced in the area. Attendees will be able to apply their learning from this satellite meeting into their daily work in API selection and a suitable technology to achieve desired release profiles.

Educational Goals for the Satellite Meeting:

  • Background into suitability of MP systems for oral
  • Latest on the formulation and design for this dosage form using various polymers and technologies
  • Practical aspects of manufacturing and scale up for MP systems
  • Up to date information on QbD and PAT aspects for MP systems
  • Potential mathematical prediction of formulation and description of drug release
  • Regulatory preferences and guidelines on MP systems as compared to monoliths

Thursday, April 3, 2008 – Topics and Speakers*

09:00 – 09:30Opening Remarks and Scope of the Satellite Meeting - Market Trends
Co-chairs: Ali R. Rajabi-Siahboomi, Colorcon, Inc., U.S.A. and Gurvinder Singh Rekhi, Elan Drug Technologies, U.S.A.
09:30 – 10:15Suitability of GIT for Specialized Multi-Unit Drug Delivery Systems
Clive Wilson, University of Strathclyde, Scotland
10:30 – 11:10Multi-Units from Nano to Millimeter: Formulation Approaches, Challenges and Opportunities
Reza Fassihi, Temple University, U.S.A.
11:10 – 11:40Principles of Drug Layering on Pellets for Modified Release Formulations
Amina Faham, Colorcon, Inc., U.S.A.
11:40 – 12:10Critical Physico-Mechanical Properties of the Barrier Membrane Films Influencing Performance on Coated Multi-Particulate Systems
Charles Vesey, Colorcon, Inc., U.S.A.
13:30 – 14:00Modulation of a Consistent Drug Release from Barrier Membrane Coated Multi-Particulates
Kurt Fegely, Colorcon, Inc., U.S.A.
14:00 – 14:45 The Principal Criteria for Polymer Selection in Multi-Particulate Systems
Yidan Lan, BASF Pharma Solutions, U.S.A.
14:45 – 15:15Scale-Up of Fluidbed Systems and PAT
Marcus Knöll, Hüttlin GmbH, Germany
15:45 – 16:30Encapsulation of Multi-Particulates: Critical Process Parameters and Performance Variables
Matt Richardson, CAPSUGEL, U.S.A.
16:30 – 17:30Interactive session: Panel Discussion; Question and Answer

Friday, April 4, 2008 - Topics and Speakers*

08:00 – 08:45Approaches for Multi-Particulate Design and Manufacture: A Case Study
Richard Sidwell, Elan Drug Technologies, U.S.A.
08:45 – 09:20In-vitro Dissolution Testing of Multi-Particulate Systems for In-vivo Performance Prediction
Rob Havenaar, TNO, The Netherlands
09:20 – 10:00In-vitro Dissolution Testing of Multi-Particulate Systems Using USP Dissolution Apparatus I, II and III
Sandra Klein, Johann Wolfgang Goethe University, Germany
10:30 – 11:30Use of Functional Polymers on Multi-Particulate Systems for Design of Drug Delivery to Site Specific Regions of the GIT
Brigitte Skalsky, Evonik Industries AG, Germany
11:30 – 12:10Mathematical Description for Predictive Modeling of Drug Release and Formulation Design
Viera Lukacova, Simulations Plus Inc., U.S.A.
13:30 – 14:15Lipidic Multi-Unit Systems for Oral Drug Delivery
Jasmine Musakhanian, Gattefosse Corporation, Canada
14:15 – 15:00Quality by Design Aspects of Multi-Particulate Systems: Formulation and Related Processing
Chris Moreton, FinnBrit Consulting, U.S.A.
15:30 – 16:15Multi-Particulate Systems versus Single Units, A Regulatory Perspective and Preferences
Mansoor Khan, Food & Drug Administration, U.S.A.
16:15 – 16:45Interactive session: Panel Discussion; Question and Answer
16:45 – 17:00Concluding Remarks and Close
Co-chairs: Ali R. Rajabi-Siahboomi, Colorcon, Inc., U.S.A. and Gurvinder Singh Rekhi, Elan Drug Technologies, U.S.A.

*Topics and speakers subject to change.



© Copyright The Controlled Release Society
Contact CRS  |  Webmaster  |  Report a bug